M. Hauger

Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies.

C. Shapiro, E. Kraut, G. Otterson, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients

B. Ramaswamy, C. Shapiro, Helen X. Chen, 2006, Clinical Cancer Research.

Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel Followed by Epirubicin in Stage II/III Breast Cancer

B. Ramaswamy, C. Shapiro, R. Orlowski, 2005, Breast Cancer Research and Treatment.

Phase II Trial of Bevacizumab in Combination with Weekly Docetaxel in Metastatic Breast Cancer Patients

B. Ramaswamy, C. Shapiro, Helen X. Chen, 2006, Clinical Cancer Research.

Age-dependent levels of plasma neuropeptides in normal children

T. O'Dorisio, M. O'dorisio, M. Hauger, 2002, Regulatory Peptides.

Phase II study of weekly docetaxel and capecitabine in patients with metastatic breast cancer.

B. Ramaswamy, C. Shapiro, M. Villalona-Calero, 2006, Clinical breast cancer.